B: Neo-antigen counts plotted against mutation burden (mutations per Mb) revealed a trend towards significance based on a Pearson’s correlation.
← all excerpts
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
1
—
—